Sign in

CIK 0001810182

  • Non-accelerated filer
  • Smaller reporting company

ALX ONCOLOGY HOLDINGS INC

Sign in to watch
Ticker
ALXO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
850642577
Phone
+1 650-466-7125
Business address
323 ALLERTON AVENUE, SOUTH SAN FRANCISCO, CA, 94080
  1. 4 Open-market buy Director bought 30,000 shares at $1.55 ($46,404)
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Open-market sale SVP, FINANCE AND CAO sold 564 shares at $2.58 ($1,455)
  6. 4 Open-market sale CHIEF MEDICAL OFFICER sold 1,365 shares at $2.58 ($3,522)
  7. 4 Shares withheld for taxes CHIEF FINANCIAL OFFICER gave up 761 shares (to pay taxes)
  8. 4 Open-market sale PRESIDENT & CSO sold 1,937 shares at $2.58 ($4,997)
  9. 4 Shares withheld for taxes CHIEF EXECUTIVE OFFICER gave up 2,191 shares (to pay taxes)
  10. 4 Derivatives Options or other derivatives
  11. 3 Insider Initial Statement of Ownership
  12. 4 Planned sale PRESIDENT & CSO sold 20,000 shares at $7.90 ($158,076)
  13. 4 Open-market sale SVP, FINANCE AND CAO sold 1,823 shares at $5.50 ($10,025)
  14. 4 Open-market sale SVP, FINANCE AND CAO sold 1,373 shares at $5.82 ($7,989)
  15. 4 Open-market sale CHIEF MEDICAL OFFICER sold 3,273 shares at $5.82 ($19,045)
  16. 4 Open-market sale PRESIDENT & CSO sold 10,758 shares at $5.82 ($62,599)
  17. 4 Shares withheld for taxes CHIEF FINANCIAL OFFICER gave up 1,789 shares (to pay taxes)
  18. 4/A Open-market buy CHIEF FINANCIAL OFFICER bought 12,000 shares at $8.53 ($102,338)
  19. 4 Open-market buy CHIEF FINANCIAL OFFICER bought 12,000 shares at $8.53 ($102,338)
  20. 4 Derivatives Options or other derivatives

Page 4 of 11 · 213 filings